Manmeet S. Soni
2017 - Alnylam Pharmaceuticals
In 2017, Manmeet S. Soni earned a total compensation of $4.5M as Senior Vice President, Chief Financial Officer principal financial officer at Alnylam Pharmaceuticals.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $165,620 |
| Option Awards | $3,853,400 |
| Salary | $318,500 |
| Other | $44,180 |
| Total | $4,481,700 |
Soni received $3.9M in option awards, accounting for 86% of the total pay in 2017.
Soni also received $100K in bonus, $165.6K in non-equity incentive plan, $318.5K in salary and $44.2K in other compensation.
Rankings
In 2017, Manmeet S. Soni's compensation ranked 2,203rd out of 14,666 executives tracked by ExecPay. In other words, Soni earned more than 85.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,203 out of 14,666 | 85th |
Division Manufacturing | 758 out of 5,772 | 87th |
Major group Chemicals And Allied Products | 205 out of 2,075 | 90th |
Industry group Drugs | 154 out of 1,731 | 91st |
Industry Pharmaceutical Preparations | 120 out of 1,333 | 91st |
Source: SEC filing on March 23, 2018.
Soni's colleagues
We found six more compensation records of executives who worked with Manmeet S. Soni at Alnylam Pharmaceuticals in 2017.
2017
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
2017
Yvonne Greenstreet
Alnylam Pharmaceuticals
Chief Operating Officer
2017
Barry Greene
Alnylam Pharmaceuticals
President
2017
Akshay Vaishnaw
Alnylam Pharmaceuticals
President, Research and Development
2017
Michael Mason
Alnylam Pharmaceuticals
Vice President of Finance and Treasurer former principal financial officer
2017
David-Alexandre Gros
Alnylam Pharmaceuticals